ALLERNAZE Drug Patent Profile
✉ Email this page to a colleague
When do Allernaze patents expire, and what generic alternatives are available?
Allernaze is a drug marketed by Lupin Atlantis and is included in one NDA.
The generic ingredient in ALLERNAZE is triamcinolone acetonide. There is one drug master file entry for this compound. Eighty suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Allernaze
A generic version of ALLERNAZE was approved as triamcinolone acetonide by SUN PHARMA CANADA on October 1st, 1986.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for ALLERNAZE?
- What are the global sales for ALLERNAZE?
- What is Average Wholesale Price for ALLERNAZE?
Summary for ALLERNAZE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Patent Applications: | 4,780 |
| What excipients (inactive ingredients) are in ALLERNAZE? | ALLERNAZE excipients list |
| DailyMed Link: | ALLERNAZE at DailyMed |
US Patents and Regulatory Information for ALLERNAZE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin Atlantis | ALLERNAZE | triamcinolone acetonide | SPRAY, METERED;NASAL | 020120-001 | Feb 4, 2000 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
